{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T10:17:51Z","timestamp":1789985871072,"version":"4.0.1"},"reference-count":35,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.3892\/or.2016.5313","type":"journal-article","created":{"date-parts":[[2016,12,14]],"date-time":"2016-12-14T03:05:04Z","timestamp":1481684704000},"page":"1168-1174","source":"Crossref","is-referenced-by-count":42,"title":["Thioridazine elicits potent antitumor effects in colorectal cancer stem cells"],"prefix":"10.3892","volume":"37","author":[{"given":"Chen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2016,12,14]]},"reference":[{"key":"key20180107224800_b1-or-37-02-1168","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/s00280-003-0738-1","article-title":"Phenothiazines suppress proliferation and induce apoptosis in cultured leukemic cells without any influence on the viability of normal lymphocytes. Phenothiazines and leukemia","volume":"53","author":"Zhelev","year":"2004","journal-title":"Cancer Chemother Pharmacol"},{"key":"key20180107224800_b2-or-37-02-1168","doi-asserted-by":"crossref","first-page":"e1063","DOI":"10.1038\/cddis.2014.35","article-title":"Antipsychotic agent thioridazine sensitizes renal carcinoma Caki cells to TRAIL-induced apoptosis through reactive oxygen species-mediated inhibition of Akt signaling and downregulation of Mcl-1 and c-FLIP(L)","volume":"5","author":"Min","year":"2014","journal-title":"Cell Death Dis"},{"key":"key20180107224800_b3-or-37-02-1168","doi-asserted-by":"crossref","first-page":"e1753","DOI":"10.1038\/cddis.2015.77","article-title":"Identification of thioridazine, an antipsychotic drug, as an antiglioblastoma and anticancer stem cell agent using public gene expression data","volume":"6","author":"Cheng","year":"2015","journal-title":"Cell Death Dis"},{"key":"key20180107224800_b4-or-37-02-1168","first-page":"266","article-title":"Thioridazine in the management of cancer-related sweating","volume":"15","author":"Cowap","year":"1998","journal-title":"J Pain Symptom Manage"},{"issue":"viii","key":"key20180107224800_b5-or-37-02-1168","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0889-8588(02)00018-7","article-title":"Fever and sweats in the patient with advanced cancer","volume":"16","author":"Zhukovsky","year":"2002","journal-title":"Hematol Oncol Clin North Am"},{"key":"key20180107224800_b6-or-37-02-1168","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1191\/0269216302pm570oa","article-title":"Depression in palliative care: A systematic review. Part 2. Treatment","volume":"16","author":"Ly","year":"2002","journal-title":"Palliat Med"},{"key":"key20180107224800_b7-or-37-02-1168","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10495-012-0717-2","article-title":"Thioridazine induces apoptosis by targeting the PI3K\/Akt\/mTOR pathway in cervical and endometrial cancer cells","volume":"17","author":"Kang","year":"2012","journal-title":"Apoptosis"},{"key":"key20180107224800_b8-or-37-02-1168","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.ygyno.2010.10.003","article-title":"A gene signature-based approach identifies thioridazine as an inhibitor of phosphatidylinositol-3-kinase (PI3K)\/AKT pathway in ovarian cancer cells","volume":"120","author":"Rho","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180107224800_b9-or-37-02-1168","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1007\/s13277-014-2278-1","article-title":"Thioridazine specifically sensitizes drug-resistant cancer cells through highly increase in apoptosis and P-gp inhibition","volume":"35","author":"Choi","year":"2014","journal-title":"Tumour Biol"},{"key":"key20180107224800_b10-or-37-02-1168","first-page":"1543","article-title":"Roles of dopamine receptors and their antagonist thioridazine in hepatoma metastasis","volume":"8","author":"Lu","year":"2015","journal-title":"Onco Targets Ther"},{"key":"key20180107224800_b11-or-37-02-1168","first-page":"727","article-title":"Mechanism of killing effect of thioridazine on human lung cancer PC9 cells","volume":"18","author":"Gong","year":"2015","journal-title":"Zhongguo Fei Ai Za Zhi"},{"key":"key20180107224800_b12-or-37-02-1168","doi-asserted-by":"crossref","first-page":"4103","DOI":"10.3892\/mmr.2015.3967","article-title":"Dopamine receptor antagonist thioridazine inhibits tumor growth in a murine breast cancer model","volume":"12","author":"Yin","year":"2015","journal-title":"Mol Med Rep"},{"key":"key20180107224800_b13-or-37-02-1168","first-page":"1540","article-title":"Mechanism of thioridazine plus medroxyprogesterone in the treatment of endometrial cancer","volume":"95","author":"Meng","year":"2015","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"key20180107224800_b14-or-37-02-1168","first-page":"511","article-title":"Mechanism of thioridazine-induced apoptosis of human colorectal cancer SW480 cells","volume":"35","author":"Liu","year":"2015","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"key20180107224800_b15-or-37-02-1168","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1016\/j.cell.2012.03.049","article-title":"Identification of drugs including a dopamine receptor antagonist that selectively target cancer stem cells","volume":"149","author":"Sachlos","year":"2012","journal-title":"Cell"},{"key":"key20180107224800_b16-or-37-02-1168","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/j.biomaterials.2013.10.049","article-title":"Co-delivery of thioridazine and doxorubicin using polymeric micelles for targeting both cancer cells and cancer stem cells","volume":"35","author":"Ke","year":"2014","journal-title":"Biomaterials"},{"key":"key20180107224800_b17-or-37-02-1168","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nbt0109-44","article-title":"Looking ahead in cancer stem cell research","volume":"27","author":"Dick","year":"2009","journal-title":"Nat Biotechnol"},{"key":"key20180107224800_b18-or-37-02-1168","doi-asserted-by":"crossref","first-page":"3142","DOI":"10.1182\/blood-2002-10-3062","article-title":"Detection, isolation, and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML)","volume":"101","author":"Guan","year":"2003","journal-title":"Blood"},{"key":"key20180107224800_b19-or-37-02-1168","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"key20180107224800_b20-or-37-02-1168","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.3390\/md13031340","article-title":"The anticancer effect of (1S,2S,3E,7E,11E)-3,7,11, 15-cembratetraen-17,2-olide(LS-1) through the activation of TGF-\u03b2 signaling in SNU-C5\/5-FU, fluorouracil-resistant human colon cancer cells","volume":"13","author":"Kim","year":"2015","journal-title":"Mar Drugs"},{"key":"key20180107224800_b21-or-37-02-1168","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.3892\/or.2015.4253","article-title":"Salinomycin inhibits the growth of colorectal carcinoma by targeting tumor stem cells","volume":"34","author":"Zhang","year":"2015","journal-title":"Oncol Rep"},{"key":"key20180107224800_b22-or-37-02-1168","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1093\/jac\/38.6.1049","article-title":"Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: Potential use for initial therapy of freshly diagnosed tuberculosis","volume":"38","author":"Amaral","year":"1996","journal-title":"J Antimicrob Chemother"},{"key":"key20180107224800_b23-or-37-02-1168","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2174\/157489111796064533","article-title":"Global clinical trials for the treatment of TB with thioridazine","volume":"6","author":"Boeree","year":"2011","journal-title":"Recent Pat Antiinfect Drug Discov"},{"key":"key20180107224800_b24-or-37-02-1168","first-page":"2341","article-title":"A method of alleviation of pain in cancer patients. Clinical trial of thioridazine (Melleril and Mellerettes) in 251 patients","volume":"103","author":"Kleibel","year":"1961","journal-title":"Munch Med Wochenschr"},{"key":"key20180107224800_b25-or-37-02-1168","first-page":"52","article-title":"Haloperidol and thioridazine drug levels and clinical response in schizophrenia: Comparison of gas-liquid chromatography and radioreceptor drug level assays","volume":"21","author":"Smith","year":"1985","journal-title":"Psychopharmacol Bull"},{"key":"key20180107224800_b26-or-37-02-1168","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.3892\/or.2014.3068","article-title":"Thioridazine, an antipsychotic drug, elicits potent antitumor effects in gastric cancer","volume":"31","author":"Mu","year":"2014","journal-title":"Oncol Rep"},{"key":"key20180107224800_b27-or-37-02-1168","doi-asserted-by":"crossref","first-page":"15364","DOI":"10.1073\/pnas.0406776101","article-title":"Translationally controlled tumor protein is a target of tumor reversion","volume":"101","author":"Tuynder","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107224800_b28-or-37-02-1168","first-page":"247","article-title":"Inhibitory effect of antipsychotic drugs on the Con A- and LPS-induced proliferative activity of mouse splenocytes: A possible mechanism of action","volume":"57","author":"Basta-Kaim","year":"2006","journal-title":"J Physiol Pharmacol"},{"key":"key20180107224800_b29-or-37-02-1168","doi-asserted-by":"crossref","first-page":"4929","DOI":"10.18632\/oncotarget.2063","article-title":"Thioridazine inhibits angiogenesis and tumor growth by targeting the VEGFR-2\/PI3K\/mTOR pathway in ovarian cancer xenografts","volume":"5","author":"Park","year":"2014","journal-title":"Oncotarget"},{"key":"key20180107224800_b30-or-37-02-1168","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S0140-6736(88)90202-4","article-title":"Thioridazine: A radiation enhancer in advanced cervical cancer?","volume":"2","author":"Hercbergs","year":"1988","journal-title":"Lancet"},{"key":"key20180107224800_b31-or-37-02-1168","doi-asserted-by":"crossref","first-page":"R233","DOI":"10.1530\/ERC-10-0334","article-title":"The role of somatostatin and dopamine D2 receptors in endocrine tumors","volume":"18","author":"Gatto","year":"2011","journal-title":"Endocr Relat Cancer"},{"key":"key20180107224800_b32-or-37-02-1168","first-page":"839","article-title":"Circumvention of multiple-drug resistance in human cancer cells by thioridazine, trifluoperazine, and chlorpromazine","volume":"76","author":"Akiyama","year":"1986","journal-title":"J Natl Cancer Inst"},{"key":"key20180107224800_b33-or-37-02-1168","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0304-3835(93)90231-W","article-title":"Reversal of doxorubicin-resistance in sarcoma 180 tumor cells by inhibition of different resistance mechanisms","volume":"70","author":"Efferth","year":"1993","journal-title":"Cancer Lett"},{"key":"key20180107224800_b34-or-37-02-1168","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1017\/S146114571100109X","article-title":"The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3","volume":"15","author":"Sutton","year":"2012","journal-title":"Int J Neuropsychopharmacol"},{"key":"key20180107224800_b35-or-37-02-1168","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s12038-007-0073-5","article-title":"Synergy between verapamil and other multidrug -resistance modulators in model membranes","volume":"32","author":"Castaing","year":"2007","journal-title":"J Biosci"}],"container-title":["Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/or.2016.5313\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:01:29Z","timestamp":1515348089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/or.2016.5313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,14]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,12,14]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3892\/or.2016.5313"],"URL":"https:\/\/doi.org\/10.3892\/or.2016.5313","relation":{},"ISSN":["1021-335X","1791-2431"],"issn-type":[{"value":"1021-335X","type":"print"},{"value":"1791-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,14]]}}}